Dr Kate Eason

June 15, 2020

Kate works with data from the Personalised Breast Cancer Programme and is interested in how different types of high-dimensional molecular data can be integrated and reconciled with clinicopathological information, and how this integrated understanding can then be used in personalised medicine.

 

Dr Kate Eason
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect